{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:18:01Z","timestamp":1792293481042,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Biology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.repbio.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T08:38:55Z","timestamp":1570610335000},"page":"309-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome"],"prefix":"10.1016","volume":"19","author":[{"given":"Beata","family":"Banaszewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Pawelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Spaczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repbio.2019.09.006_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0010","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod (Oxf Engl)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0025","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod (Oxf Engl)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0030","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.repbio.2019.09.006_bib0035","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/en.2012-1366","article-title":"Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction","volume":"153","author":"Franks","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.repbio.2019.09.006_bib0040","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.repbio.2019.09.006_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0050","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/humrep\/deu282","article-title":"Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome","volume":"29","author":"Liu","year":"2014","journal-title":"Hum Reprod (Oxf Engl)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0055","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/14737159.2017.1340833","article-title":"Genetics of polycystic ovary syndrome","volume":"17","author":"Mykhalchenko","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.repbio.2019.09.006_bib0060","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fertnstert.2013.05.023","article-title":"Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood","volume":"100","author":"Abbott","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.fertnstert.2016.04.040","article-title":"Genetic determinants of polycystic ovary syndrome: progress and future directions","volume":"106","author":"Jones","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.repbio.2019.09.006_bib0080","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-156-3-201202070-00011","article-title":"Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American college of physicians","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.repbio.2019.09.006_bib0090","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-15-0447","article-title":"Current understanding of metformin effect on the control of hyperglycemia in diabetes","volume":"228","author":"An","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.repbio.2019.09.006_bib0095","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0100","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1210\/en.2012-1145","article-title":"Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain","volume":"153","author":"Hirsch","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.repbio.2019.09.006_bib0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.repbio.2019.09.006_bib0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin improves hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0115","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repbio.2019.09.006_bib0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repbio.2019.09.006_bib0125","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00125-017-4361-9","article-title":"Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program\/Diabetes Prevention Program Outcomes Study","volume":"60","author":"Aroda","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.repbio.2019.09.006_bib0130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.repbio.2019.09.006_bib0135","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repbio.2019.09.006_bib0140","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/humrep\/der154","article-title":"Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study","volume":"26","author":"Kjotrod","year":"2011","journal-title":"Hum Reprod (Oxf Engl)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0145","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.fertnstert.2011.09.020","article-title":"Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial","volume":"96","author":"Palomba","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1471-0528.12070","article-title":"Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials","volume":"120","author":"Palomba","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.repbio.2019.09.006_bib0155","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/humrep\/dew268","article-title":"A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial","volume":"31","author":"Jacob","year":"2016","journal-title":"Hum Reprod (Oxf Engl)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0160","first-page":"CD012103","article-title":"Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews","volume":"1","author":"Mourad","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repbio.2019.09.006_bib0165","first-page":"CD009090","article-title":"Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome","volume":"1","author":"Bordewijk","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repbio.2019.09.006_bib0170","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014PART 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.repbio.2019.09.006_bib0175","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ibanez","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.repbio.2019.09.006_bib0180","doi-asserted-by":"crossref","first-page":"E204","DOI":"10.1210\/jc.2010-0145","article-title":"Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome","volume":"95","author":"Gambineri","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0185","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2007-1736","article-title":"Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0190","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod (Oxf Engl)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0195","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0200","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Lovvik","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.repbio.2019.09.006_bib0205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","article-title":"Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial","volume":"3","author":"Hanem","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"10.1016\/j.repbio.2019.09.006_bib0210","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10815-018-1213-6","article-title":"Why AMPK agonists not known to be stressors may surprisingly contribute to miscarriage or hinder IVF\/ART","volume":"35","author":"Puscheck","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.repbio.2019.09.006_bib0215","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.fertnstert.2004.11.051","article-title":"Placental passage of metformin in women with polycystic ovary syndrome","volume":"83","author":"Vanky","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0220","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2337\/dc11-0660","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age","volume":"34","author":"Rowan","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.repbio.2019.09.006_bib0225","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.repbio.2019.09.006_bib0230","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1210\/jcem.87.4.8412","article-title":"Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond","volume":"87","author":"McFarlane","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0235","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/j.repbio.2019.09.006_bib0240","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","article-title":"Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis","volume":"82","author":"Izquierdo","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0245","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200868130-00001","article-title":"HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?","volume":"68","author":"Kodaman","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.repbio.2019.09.006_bib0250","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1210\/jc.2010-0770","article-title":"Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability","volume":"95","author":"Sokalska","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.111.094714","article-title":"Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells","volume":"86","author":"Ortega","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.repbio.2019.09.006_bib0260","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.repbio.2019.09.006_bib0265","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","article-title":"Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial","volume":"85","author":"Duleba","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0270","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1210\/jc.2009-1674","article-title":"Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial","volume":"94","author":"Banaszewska","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0275","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1210\/jc.2011-0501","article-title":"Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment","volume":"96","author":"Banaszewska","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0280","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.fertnstert.2009.11.045","article-title":"Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study","volume":"94","author":"Kazerooni","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/09513590.2017.1418853","article-title":"Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome","volume":"34","author":"Seyam","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.repbio.2019.09.006_bib0290","first-page":"CD008565","article-title":"Statins for women with polycystic ovary syndrome not actively trying to conceive","author":"Raval","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repbio.2019.09.006_bib0295","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/jc.2013-2674","article-title":"Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study","volume":"98","author":"Puurunen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0300","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007280","article-title":"An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials","volume":"5","author":"Sun","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.repbio.2019.09.006_bib0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11883-019-0780-z","article-title":"Diabetogenic action of statins: mechanisms","volume":"21","author":"Carmena","year":"2019","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.repbio.2019.09.006_bib0310","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1039\/C8FO01997E","article-title":"The effects of polyphenols and other bioactives on human health","volume":"10","author":"Fraga","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.repbio.2019.09.006_bib0315","doi-asserted-by":"crossref","DOI":"10.3390\/nu10121892","article-title":"Health effects of resveratrol: results from human intervention trials","volume":"10","author":"Ramirez-Garza","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.repbio.2019.09.006_bib0320","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/CH-2011-1424","article-title":"Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease","volume":"50","author":"Magyar","year":"2012","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.repbio.2019.09.006_bib0325","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1017\/S0007114511000316","article-title":"Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients","volume":"106","author":"Brasnyo","year":"2011","journal-title":"Br J Nutr"},{"key":"10.1016\/j.repbio.2019.09.006_bib0330","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12986-017-0217-z","article-title":"Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis","volume":"14","author":"Zhu","year":"2017","journal-title":"Nutr Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0335","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.fertnstert.2011.08.010","article-title":"Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells","volume":"96","author":"Wong","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.repbio.2019.09.006_bib0340","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1210\/jc.2016-1858","article-title":"Effects of resveratrol on polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial","volume":"101","author":"Banaszewska","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.repbio.2019.09.006_bib0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.rbmo.2012.10.007","article-title":"Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS?","volume":"26","author":"Kim","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.repbio.2019.09.006_bib0350","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1933719117711262","article-title":"Melatonin treatment may be able to restore menstrual cyclicity in women with PCOS: a pilot study","volume":"25","author":"Tagliaferri","year":"2018","journal-title":"Reprod Sci (Thousand Oaks, Calif)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0355","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1471-0528.14754","article-title":"Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials","volume":"125","author":"Pundir","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.repbio.2019.09.006_bib0360","first-page":"Cd012378","article-title":"Inositol for subfertile women with polycystic ovary syndrome","volume":"12","author":"Showell","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.repbio.2019.09.006_bib0365","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1570161114666161221115324","article-title":"Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome","volume":"15","author":"Tzotzas","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.repbio.2019.09.006_bib0370","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humupd\/dmz019","article-title":"The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective","volume":"25","author":"Jensterle","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.repbio.2019.09.006_bib0375","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle Sever","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.repbio.2019.09.006_bib0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07435800.2014.966385","article-title":"Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome","volume":"40","author":"Jensterle","year":"2015","journal-title":"Endocr Res"},{"key":"10.1016\/j.repbio.2019.09.006_bib0385","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12902-017-0155-9","article-title":"Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial","volume":"17","author":"Jensterle","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.repbio.2019.09.006_bib0390","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","author":"Jensterle","year":"2015","journal-title":"Hormones (Athens Greece)"},{"key":"10.1016\/j.repbio.2019.09.006_bib0395","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod Biomed Online"}],"container-title":["Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X19302062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1642431X19302062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:19:05Z","timestamp":1761646745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1642431X19302062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1642431X19302062"],"URL":"https:\/\/doi.org\/10.1016\/j.repbio.2019.09.006","relation":{},"ISSN":["1642-431X"],"issn-type":[{"value":"1642-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repbio.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of Society for Biology of Reproduction & the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn.","name":"copyright","label":"Copyright"}]}}